Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

A treatment bridge for infants with hemophilia

Thomas C. Abshire

Blood (2024) 143 (14): 1317–1318.

https://doi.org/10.1182/blood.2023023576

Published: 2024

Journal Articles

Clinical Characteristics, Treatment, and Outcomes of Provoked Acute Cerebral Sinovenous Thrombosis in Patients <21 Years Old: Findings from the Kids-DOTT Multinational Trial

Gary Woods, Alexandra Miller, Maua Mosha, Christoph Male, Anupam Verma, Nicole Kucine, Christine Sabapathy, Kisha A Beg, Sanjay Ahuja, Deepti A. Raybagkar, Kerry Hege, Clara Lo, Rukhmi Bhat, Thomas C. Abshire, Neil Goldenberg

Blood (2023) 142 (Supplement 1): 808.

https://doi.org/10.1182/blood-2023-182167

Published: 2023

Journal Articles

Real World Use of Extended Half-Life Products and the Impact on Bleeding Events and Joint Health in the United States

Lynn M. Malec, MD, Char M Witmer, MDMSCE, Julie Jaffray, MD, Peter A. Kouides, MD, Kristina M. Haley, DO, Robert F. Sidonio, Jr., MD, Dunlei Cheng, PhD, Thomas C. Abshire, MD, Gilbert C. White, MD, Margaret V. Ragni, MD MPH

Blood (2018) 132 (Supplement 1): 1195.

https://doi.org/10.1182/blood-2018-99-113956

Published: 2018

Journal Articles

Prospective Diagnosis of VWD in a Large Cohort of Patients with Bleeding Symptoms through the Zimmerman Program

Veronica H Flood, MD, Pamela A Christopherson, Joan Cox Gill, MD, Kenneth Dale Friedman, MD, Sandra L Haberichter, PhD, Jorge Di Paola, MD, Paula D. James, MD, Janna M. Journeycake, MD, Steven R. Lentz, MD PhD, Cindy A. Leissinger, MD, Margaret V. Ragni, MD MPH, Madhvi Rajpurkar, MD, Jonathan C. Roberts, MD, Amy Shapiro, Robert F. Sidonio, Robert R Montgomery, MD, Thomas C. Abshire, MD

Blood (2018) 132 (Supplement 1): 979.

https://doi.org/10.1182/blood-2018-99-110650

Published: 2018

Journal Articles

Contribution of Select ISTH-BAT Subscores to the Total Score in Type 1 VWD

Jessica Garcia, MD, Pamela A Christopherson, Veronica H Flood, MD, Joan Cox Gill, MD, Robert R. Montgomery, MD, Paula D. James, MD, Pippa Simpson, PhD, Liyun Zhang, MS, Thomas C. Abshire, MD, Zimmerman Program Investigators

Blood (2017) 130 (Supplement 1): 1075.

https://doi.org/10.1182/blood.V130.Suppl_1.1075.1075

Published: 2017

Journal Articles

Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States

Blood (2016) 127 (20): 2481–2488.

https://doi.org/10.1182/blood-2015-10-673681

Published: 2016

Includes: Supplemental data

Journal Articles

Non-Factor VIII Coagulation Proteins Fail to Predict Joint Outcome in Severe Hemophilia a

Beth Boulden Warren, MD MS, Linda Jacobsen, BS, Elizabeth Villalobos-Menuey, BS, Thomas C. Abshire, MD, Amy D Shapiro, MD, Michael Recht, MD PhD, Deborah Brown, MD, Cindy A. Leissinger, MD, Christine L. Kempton, MD MSc, Heidi Lane, PT, DPT, PCS, Diane J. Nugent, MD, Marilyn J. Manco-Johnson, MD

Blood (2015) 126 (23): 2289.

https://doi.org/10.1182/blood.V126.23.2289.2289

Published: 2015

Journal Articles

Pilot/Feasibility Metrics, Real-Time Remote Monitoring, and Inter-Observer Agreement on Veno-Occlusion in a National Multicenter Randomized Controlled Trial of Pediatric Venous Thromboembolism: Findings from the Pilot/Feasibility Phase of the Kids-DOTT Trial

Neil A Goldenberg, MD PhD, Thomas C. Abshire, MD, Jonathan L Halperin, MD, William R. Hiatt, Craig M. Kessler, MD, John M Kittelson, PhD, Marilyn J. Manco-Johnson, MD, Alex Spyropoulos, MD, Phillipe Gabriel Steg, MD, Alexander G.G. Turpie, MD, Sam Schulman, MD PhD

Blood (2014) 124 (21): 4271.

https://doi.org/10.1182/blood.V124.21.4271.4271

Published: 2014

Journal Articles

Impact of Age and Gender on Bleeding Score in Type 1 VWD Using the ISTH-BAT

Pamela A Christopherson, Veronica H Flood, MD, Kenneth D. Friedman, MD, Joan Cox Gill, MD, Sandra L Haberichter, PhD, Robert R Montgomery, MD, Thomas C. Abshire, MD, the Zimmerman Program Investigators

Blood (2014) 124 (21): 1510.

https://doi.org/10.1182/blood.V124.21.1510.1510

Published: 2014

Journal Articles

An Intensive Model Of Care For Adults With Sickle Cell Disease That Rapidly Reduces Hospital Admissions, Readmissions and Cost

Kathryn L. Koch, MSN, FNP-BC, Cynthia L. Leonard, MSN, RN, Katherine Bagemihl, MS, David Marks, MD, MBA, Thomas C. Abshire, Joshua J. Field, MD, MS

Blood (2013) 122 (21): 773.

https://doi.org/10.1182/blood.V122.21.773.773

Published: 2013

Journal Articles

The Complete Type I VWD Cohort Of The Zimmerman Program For The Molecular and Clinical Biology Of VWD - Phenotypic Assignment, Mutation Frequency, and Bleeding Assessment

Robert R. Montgomery, MD, Pamela Christopherson, Daniel B. Bellissimo, Joan Cox Gill, Sandra L. Haberichter, Veronica H. Flood, MD, David Lillicrap, Anne C. Goodeve, Kenneth D Friedman, Thomas C. Abshire, Amy D. Shapiro, Margaret V. Ragni, Steven R. Lentz, Cindy A. Leissinger, Amy L. Dunn, Jeanne Lusher, Deborah Brown

Blood (2013) 122 (21): 332.

https://doi.org/10.1182/blood.V122.21.332.332

Published: 2013

Journal Articles

No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation

Veronica H. Flood, Kenneth D. Friedman, Joan Cox Gill, Sandra L. Haberichter, Pamela A. Christopherson, Brian R. Branchford, Raymond G. Hoffmann, Thomas C. Abshire, Amy L. Dunn, Jorge A. Di Paola, W. Keith Hoots, Deborah L. Brown, Cindy Leissinger, Jeanne M. Lusher, Margaret V. Ragni, Amy D. Shapiro, Robert R. Montgomery

Blood (2013) 121 (18): 3742–3744.

https://doi.org/10.1182/blood-2012-12-471672

Published: 2013

Journal Articles

VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population

Daniel B. Bellissimo, Pamela A. Christopherson, Veronica H. Flood, Joan Cox Gill, Kenneth D. Friedman, Sandra L. Haberichter, Amy D. Shapiro, Thomas C. Abshire, Cindy Leissinger, W. Keith Hoots, Jeanne M. Lusher, Margaret V. Ragni, Robert R. Montgomery

Blood (2012) 119 (9): 2135–2140.

https://doi.org/10.1182/blood-2011-10-384610

Published: 2012

Journal Articles

Regular Replacement Therapy as Prophylaxis In Severe Forms of Von Willebrand Disease: Initial Results From the Von Willebrand Disease Prophylaxis Network (VWD PN) Study Group

Erik Berntorp, MD, PhD, Thomas C. Abshire, MD, Augusto B. Federici, MD

Blood (2010) 116 (21): 236.

https://doi.org/10.1182/blood.V116.21.236.236

Published: 2010

Journal Articles

Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor

Veronica H. Flood, Joan Cox Gill, Patricia A. Morateck, Pamela A. Christopherson, Kenneth D. Friedman, Sandra L. Haberichter, Brian R. Branchford, Raymond G. Hoffmann, Thomas C. Abshire, Jorge A. Di Paola, W. Keith Hoots, Cindy Leissinger, Jeanne M. Lusher, Margaret V. Ragni, Amy D. Shapiro, Robert R. Montgomery

Blood (2010) 116 (2): 280–286.

https://doi.org/10.1182/blood-2009-10-249102

Published: 2010

Journal Articles

Risk Factors for Inhibitor Development in Mild and Moderate Hemophilia A: A Case-Control Study.

Christine L Kempton, MD, MSc, J. Michael Soucie, Ph.D, Connie H. Miller, PhD, Craig Hooper, PhD, Miguel A. Escobar, MD, Mark T. Reding, MD, Alice J. Cohen, MD, Nigel S. Key, MBChB, Arthur R. Thompson, M.D., Ph.D., Marilyn J. Manco-Johnson, Thomas C. Abshire, MD

Blood (2009) 114 (22): 3184.

https://doi.org/10.1182/blood.V114.22.3184.3184

Published: 2009

Journal Articles

The Kids-DOTT Trial: Novel Aspects of the ‘Parallel Cohort RCT‘ Design and Its Application to the Investigation of Duration of Anticoagulant Therapy for Pediatric Venous Thromboembolism.

Neil A. Goldenberg, MD, PhD, Mark Tripputi, PhD, MS, Mark A. Crowther, MD, Thomas C. Abshire, MD, Donna M. DiMichele, MD, Marilyn J. Manco-Johnson, William R Hiatt, MD

Blood (2009) 114 (22): 4169.

https://doi.org/10.1182/blood.V114.22.4169.4169

Published: 2009

Journal Articles

Factor VIII and Factor IX Mutation Analysis in 600 U.S. Hemophilia Patients: Correlation of Mutation Type with History of Inhibitor

Connie H. Miller, PhD, Craig Hooper, PhD, Thomas C. Abshire, MD, Paula L. Bockenstedt, MD, Doreen B. Brettler, MD, Jorge Di Paola, MD, Gita Massey, MD, Anne T. Neff, MD, Amy D. Shapiro, MD, Michael Tarantino, MD, Brian M. Wicklund, MD, MPH, Marilyn J. Manco-Johnson, MD, Amy L. Dunn, MD, Christine Knoll, MD, Melissa Creary, MPH, Jane Benson, Dorothy Ellingsen, Jennifer Driggers, J. Michael Soucie, PhD

Blood (2008) 112 (11): 1017.

https://doi.org/10.1182/blood.V112.11.1017.1017

Published: 2008

Journal Articles

U.S. Inhibitor Pilot Project: Participant Characteristics and Infusion Log Adherence.

Melissa S. Creary, MPH, John M. Soucie, PhD, Connie H. Miller, PhD, W.C. Hooper, PhD, Thomas C. Abshire, MD, Doreen B. Brettler, MD, Paula L. Pockenstedt, MD, Jorge DiPaola, MD, Gita Massey, MD, Anne T. Neff, MD, Amy D. Shapiro, MD, Michael D. Tarantino, MD, Brian M. Wicklund, MD, Donna DiMichele, MD, Hemophilia Treatment Centers

Blood (2007) 110 (11): 1162.

https://doi.org/10.1182/blood.V110.11.1162.1162

Published: 2007

Journal Articles

Allelically Mismatched Replacement Therapy Due to Common African−Restricted Haplotypes of the Factor (F)VIII Protein May Underlie the Increased Incidence of FVIII Inhibitors Observed in Hemophilia−A Patients of African−Descent.

Tom E. Howard, MD, PhD, Kevin R. Viel, BS, Karl M. Fernstrom, BS, Seema Deshpande, PhD, Afshin Ameri, MD, M. Showkat Ali, PhD, Cynthia Channell, BS, Rathi V. Iyer, MD, Raymond G. Watts, MD, Charles Lutcher, MD, Shelley Nakaya, BS, Carol K. Kasper, MD, Arthur R. Thompson, MD, PhD, Thomas C. Abshire, MD, Laura Almasy, PhD

Blood (2006) 108 (11): 765.

https://doi.org/10.1182/blood.V108.11.765.765

Published: 2006

NARROW

A treatment bridge for infants with hemophilia

Clinical Characteristics, Treatment, and Outcomes of Provoked Acute Cerebral Sinovenous Thrombosis in Patients <21 Years Old: Findings from the Kids-DOTT Multinational Trial

Real World Use of Extended Half-Life Products and the Impact on Bleeding Events and Joint Health in the United States

Prospective Diagnosis of VWD in a Large Cohort of Patients with Bleeding Symptoms through the Zimmerman Program

Contribution of Select ISTH-BAT Subscores to the Total Score in Type 1 VWD

Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States

Non-Factor VIII Coagulation Proteins Fail to Predict Joint Outcome in Severe Hemophilia a

Pilot/Feasibility Metrics, Real-Time Remote Monitoring, and Inter-Observer Agreement on Veno-Occlusion in a National Multicenter Randomized Controlled Trial of Pediatric Venous Thromboembolism: Findings from the Pilot/Feasibility Phase of the Kids-DOTT Trial

Impact of Age and Gender on Bleeding Score in Type 1 VWD Using the ISTH-BAT

An Intensive Model Of Care For Adults With Sickle Cell Disease That Rapidly Reduces Hospital Admissions, Readmissions and Cost

The Complete Type I VWD Cohort Of The Zimmerman Program For The Molecular and Clinical Biology Of VWD - Phenotypic Assignment, Mutation Frequency, and Bleeding Assessment

No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation

VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population

Regular Replacement Therapy as Prophylaxis In Severe Forms of Von Willebrand Disease: Initial Results From the Von Willebrand Disease Prophylaxis Network (VWD PN) Study Group

Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor

Risk Factors for Inhibitor Development in Mild and Moderate Hemophilia A: A Case-Control Study.

The Kids-DOTT Trial: Novel Aspects of the ‘Parallel Cohort RCT‘ Design and Its Application to the Investigation of Duration of Anticoagulant Therapy for Pediatric Venous Thromboembolism.

Factor VIII and Factor IX Mutation Analysis in 600 U.S. Hemophilia Patients: Correlation of Mutation Type with History of Inhibitor

U.S. Inhibitor Pilot Project: Participant Characteristics and Infusion Log Adherence.

Allelically Mismatched Replacement Therapy Due to Common African−Restricted Haplotypes of the Factor (F)VIII Protein May Underlie the Increased Incidence of FVIII Inhibitors Observed in Hemophilia−A Patients of African−Descent.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only